Skip to content

Medical-device intelligence

PCI: Gastrointestinal Bacterial Panel Multiplex Nucleic Acid-Based Assay System

FDA product code PCI: Gastrointestinal Bacterial Panel Multiplex Nucleic Acid-Based Assay System. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
PCI
FDA device name
Gastrointestinal Bacterial Panel Multiplex Nucleic Acid-Based Assay System
Device class
2
Regulation number
866.3990
Medical specialty
Microbiology
Review panel
MI

FDA definition

A gastrointestinal bacterial panel multiplex nucleic acid assay is a qualitative in vitro diagnostic device intended to simultaneously detect and identify multiple gastrointestinal bacterial nucleic acids extracted from human stool specimens. The detection and identification of a specific gastrointestinal bacterial nucleic acid from individuals exhibiting signs and/or symptoms of gastrointestinal infection aids in the diagnosis of gastrointestinal infection when used in conjunction with clinical evaluation and other laboratory findings.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

5 clearance records and 0 recall records in the covered releases, across 3 source company names and 1 product codes. Dated history runs from May 6, 2014 to Oct 31, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202510
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

5 matching records
Device / recordCompany in FDA recordSourceSource date
BD Enteric Bacterial Panel for BD COR System, BD Enteric Bacterial Panel plus for BD COR System, and Enteric Bacterial Panel Diluent for BD COR S…K250358 · PCIBecton, Dickinson and Company510(k)Oct 31, 2025FDA decision date
BD MAX Enteric Bacterial Panel, BD MAX Extended Enteric Bacterial PanelK214122 · PCIBecton, Dickinson and Company510(k)Jul 28, 2022FDA decision date
PanNAT STEC TestK173330 · PCIMicronics, Inc.510(k)Jun 1, 2018FDA decision date
Great Basin Stool Bacterial Pathogens PanelK163571 · PCIGreat Basin Scientific, Inc.510(k)Jul 12, 2017FDA decision date
BD MAX(TM) ENTERIC BACTERIAL PANEL;BD MAX(TM) INSTRUMENTK140111 · PCIBecton, Dickinson and Company510(k)May 6, 2014FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗